NAD+ Injections Before and After: What Research Shows, and What It Does Not
Search results are full of testimonials. Here is what published human research on NAD+ shows, and how to read any before-and-after claim.
Words by the editors ·
Short answer: there is no published controlled trial of NAD+ injections that reports before-and-after results you can rely on. A 2026 review of intravenous NAD+ found the human evidence "sparse," made up mainly of small uncontrolled studies, observational reports and case reports, and concluded it is preliminary and insufficient to support routine clinical or wellness use.1 The photos and testimonials that dominate search results are marketing. This page explains what the research does show, why a before-and-after story can mislead, and how to judge any claim.
It builds on our explainers What Is NAD+? and NAD+ injections for energy.
In brief
- A 2026 review of intravenous NAD+ found human evidence sparse, mostly small uncontrolled studies, and concluded it is insufficient to support routine clinical or wellness use.1
- In a placebo-controlled trial of 58 people with long-COVID, nicotinamide riboside raised blood NAD+ about 2.6- to 3.1-fold but did not significantly improve cognition, fatigue, sleep or mood versus placebo.2
- Within-group before-and-after changes in that trial were exploratory; the placebo comparison is what the trial was designed to test.2
- In 40 obese men, 12 weeks of nicotinamide riboside at 2,000 mg a day was safe but did not improve insulin sensitivity or body composition.3
Is there evidence for NAD+ injection before and after results?
Not in controlled form. The 2026 narrative review searched literature from 2018 to March 2026. It reported that short-term intravenous NAD+ or NMN has been associated with transient increases in circulating NAD+ and with changes in some biomarkers of oxidative stress, inflammation and metabolism. A few exploratory reports described self-reported improvement in sleep and neurologic symptoms. The authors say the clinical meaning is uncertain because of small samples, no placebo controls, varied methods and short follow-up.1
A second 2026 critical review of intravenous longevity therapy reached a similarly cautious view of the clinical evidence.4 Neither review reports a validated protocol, a typical result or a time course for injections.
What do the better human trials show?
The best-controlled studies test oral NAD+ precursors rather than injections. They show that blood NAD+ can be raised, and that raising it has not reliably changed how people feel or function.
| Study | Design | What changed | What did not |
|---|---|---|---|
| Wu 2025, long-COVID | 58 people, placebo-controlled, nicotinamide riboside 2,000 mg a day | Blood NAD+ rose 2.6- to 3.1-fold within 5 to 10 weeks | No significant difference from placebo in cognition, fatigue, sleep, anxiety or depression2 |
| Dollerup 2018, obese men | 40 men aged 40 to 70, 12 weeks, nicotinamide riboside 1,000 mg twice daily | Judged safe, no serious adverse events due to it | No improvement in insulin sensitivity, energy expenditure or body composition3 |
| Igarashi 2022, older men | Randomized, placebo-controlled, nicotinamide mononucleotide 250 mg a day for 6 or 12 weeks | Blood NAD+ rose; nominal gains in gait speed and left grip | No significant effect on body composition; authors say the nominal findings need larger studies5 |
A 2024 systematic review of NAD and NADH supplementation included 10 randomized trials with 489 participants across conditions such as chronic fatigue syndrome, older adults, Parkinson's disease and overweight. It reported good tolerability, with mild side effects such as muscle pain, fatigue, sleep disturbance and headaches, and noted effects in some conditions, with the oral NADH evidence the clearest. The review was written by authors from a pharma company and clinics, and it covers mostly oral forms, not injections.6
Why can a before-and-after story mislead?
The long-COVID trial is a useful illustration. The trial compared nicotinamide riboside with placebo and found no significant difference between groups. But when the investigators, in a post-hoc exploratory analysis, looked at everyone's change from their own baseline after 10 weeks of nicotinamide riboside, they saw significant improvements in executive functioning, fatigue severity, sleep quality and depressive symptoms. The authors treated that as a reason for larger trials, not proof.2 The trial was funded in part by a supplement company, and two authors disclosed equity in it.
That is exactly what a testimonial is: a within-person change from before to after. It looks convincing, and in a trial the comparison with placebo did not show a difference. Reasons a person can feel better after any treatment include:
- Expectation. Knowing you received a treatment can change how you rate symptoms.
- Natural fluctuation. Fatigue, mood and sleep go up and down; people tend to seek treatment when they are at a low point and then drift back.
- Other changes at once. Better sleep, less alcohol or a new routine started alongside a treatment get credited to it.
- Selection. Pages show the people who were pleased, not everyone who tried it.
Do before and after photos show anything?
No study we found reports photographic outcomes for NAD+ injections. A photo has no placebo group, uses unknown lighting and timing, and cannot show a metabolic effect. Treat any image, especially one without a named study behind it, as an advertisement. Several of the pages that top the results for this search are near-identical promotional pages with unrelated text mixed in.
What side effects are reported?
The 2026 intravenous review lists nausea, cramping, flushing and chest discomfort, and says long-term safety data are lacking.1 Oral precursor trials reported mostly mild effects and no serious events related to the supplement in the trials above.32 Injected NAD+ sold online is a compounded product. The FDA says compounded drugs are not FDA-approved and are not reviewed by the agency for safety, effectiveness or quality before they are marketed.7
How to judge a before-and-after claim
- Ask what the comparison was. A change from your own baseline is not evidence; a placebo-controlled trial is.
- Ask whether the study tested injections or an oral precursor, and in whom.
- Ask who funded it and whether the authors hold a stake in the product.
- Ask what was measured: blood NAD+ is not the same as feeling or functioning better.
- Ask a prescriber about your medicines and conditions before starting anything injected. Our look at whether NAD+ supplements are worth it and the NAD+ injection dosage chart explain why no standard dose exists.
Limits of this page
Absence of controlled trials is not proof that injections do nothing; it means we cannot say they do. The human trials above used oral forms in specific groups (people with long-COVID, obese men, older men), so they do not describe a healthy adult getting injections. The 2026 reviews are narrative or critical reviews rather than pooled trial analyses. New trials could change this picture, and we will update the page if they do.
Questions
Do NAD+ injections have before and after results?
Not in published controlled research. A 2026 review found the human evidence on intravenous NAD+ sparse and mostly uncontrolled, and called it preliminary. Photos and testimonials online are marketing, not evidence.
How long do NAD+ injections take to work?
No source establishes a time course for injections. In a long-COVID trial of an oral precursor, blood NAD+ rose within about 5 weeks, but symptom scores did not differ from placebo.
Why do some people feel better after NAD+ injections?
Several things can produce a before-and-after change: natural fluctuation, expectation, other changes at the same time and regression to the mean. A placebo-controlled design exists to separate these from a real effect.
Are the results from NAD+ pills the same as injections?
No. The better trials test oral precursors such as nicotinamide riboside and nicotinamide mononucleotide, not injections, and their findings should not be assumed to apply to injected NAD+.
What side effects have been reported with intravenous NAD+?
The 2026 review lists nausea, cramping, flushing and chest discomfort, and says long-term safety data are lacking.
Also in this edition
Part of our guide: Aging Well: NAD+, Exercise and the Male Body After 40
Notes
- Alangari A, et al. Narrative review of intravenous NAD(+) and NAD(+) precursors in wellness and translational medicine. Front Aging. 2026. PubMed 42787547.
- Wu CY, et al. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. EClinicalMedicine. 2025. PubMed 41357333.
- Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018. PubMed 29992272.
- Godic A, Townsend J. Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility. Acta Dermatovenerol Alp Pannonica Adriat. 2026. PubMed 41915584.
- Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022. PubMed 35927255.
- Gindri IM, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Am J Physiol Endocrinol Metab. 2024. PubMed 37971292.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.